Search results for " Medicina Interna"

showing 10 items of 1302 documents

Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

2013

Budd-Chiari syndrome may be defined as a heterogeneous group of vascular disorders characterized by obstruction of hepatic venous return to the level of hepatic venules, supra-hepatic veins, inferior vena cava or right atrium. The main cause of this syndrome is represented by myeloproliferative diseases and, in particular, by polycythemia vera. The latter may cause multiple splanchnic thrombosis, including portal vein thrombosis, particularly important for its clinical outcomes (ascites, collateral vessels genesis, etc.). We report 2 cases of a Budd-Chiari syndrome induced by polycythemia vera characterized by an abnormal clinical onset, both as regards subjects’ age (29 and 39 years old, r…

Budd-Chiari syndromemedicine.medical_specialtySettore MED/09 - Medicina Internalcsh:MedicineInferior vena cavaPolycythemia verapolycythemia verahemic and lymphatic diseasesAscitesmedicinePortal vein thrombosibusiness.industrylcsh:RGeneral Medicinemedicine.diseaseThrombosisSurgeryPortal vein thrombosisBudd-Chiari syndrome portal vein thrombosis myeloproliferative disease polycythemia vera.medicine.veinPortal vein thrombosis; Budd-Chiari syndrome; polycythemia vera;Budd–Chiari syndromemedicine.symptomSplanchnicbusinessVenous return curve
researchProduct

Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis

2013

Budesonidemedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologymedicine.diseaseUlcerative colitisGastroenterologyInternal medicineMedicineIn patientColitisbusinessbudesonide MMX.ulcerative colitismedicine.drugMMX
researchProduct

Plasma calprotectin levels in patients suffering from acute pancreatitis

2006

Calprotectin (Cal) concentration is elevated in acute inflammatory reactions and its increase in the plasma suggests a diagnostic potential for Cal assay. This study aimed (a) to evaluate the Cal plasma levels in patients suffering from acute pancreatitis (AP) and (b) to assess whether early assay of Cal plasma levels can be helpful in assessment of the severity of AP. Forty-six consecutive patients, median age 45 years, suffering from a first attack of AP were recruited at two medical centers. Data collected on admission included age, sex, delay between pain onset and admission, and Glasgow score. A severe outcome was defined according to the Atlanta criteria. AP was defined as edematous o…

CALPROTECTIN; ACUTE PANCREATITISAdultMalemedicine.medical_specialtyPancreatic diseaseSettore MED/09 - Medicina Internaacute pancreatitisPhysiologyEnzyme-Linked Immunosorbent AssaySeverity of Illness IndexGastroenterologyInternal medicineSeverity of illnessBlood plasmamedicineHumansAgedCalprotectinbiologybusiness.industryC-reactive proteinGastroenterologyMiddle AgedHepatologymedicine.diseasehumanitiesSurgerystomatognathic diseasesC-Reactive ProteinPancreatitisCase-Control Studiesbiological sciencesbiology.proteinPancreatitisAcute pancreatitisFemaleCalprotectinTomography X-Ray ComputedbusinessLeukocyte L1 Antigen ComplexBiomarkers
researchProduct

EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP…

2014

Background and Aims: To maximize cost/efficay of boceprevirbased triple therapy (BOC) in patients with HCV-related advanced fibrosis/cirrhosis. Methods: ITT SVR12, safety and futility rules value were evaluated in the multicenter national Italian and Spanish early access Name- Patient-Program which includes treatment-experienced patients with HCVG1-related advanced fibrosis/cirrhosis (Metavir F3/4) treated with BOC in both countries. Results: 402 patients (mean age 55 years; range 22–75), 316 (78.6%) G1b, 255 (63.4%) F4, 60 (30.9%) with oesophageal varices, 137 (34.1%) relapsers, 95 (23.6%) partial and 168 (41.8%) null responders were enrolled. Platelets count <100,000 and albumin levels <3…

CHRONIC HCVSettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaHEPATITIS CCIRRHOSISHEPATITIS C; CIRRHOSIS; CHRONIC HCV
researchProduct

FUNCTIONAL ASSESSMENT OF OLDER PERSONS: ROLE OF COMPREHENSIVE GERIATRIC ASSESSMENT IN GERIATRIC ONCOLOGY

2010

COMPREHENSIVE GERIATRIC ASSESSMENT CANCER AGING FUNCTIONAL DECLINE ADL IADLSettore MED/09 - Medicina Interna
researchProduct

The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy

2023

Background: There is a scarcity of information in literature regarding the clinical differences and comorbidities of patients affected by Coronavirus disease 2019 (COVID-19), which could clarify the different prevalence of the outcomes (composite and only death) between several Italian regions. Objective: This study aimed to assess the heterogeneity of clinical features of patients with COVID-19 upon hospital admission and disease outcomes in the northern, central, and southern Italian regions. Methods: An observational cohort multicenter retrospective study including 1210 patients who were admitted for COVID-19 in Infectious diseases, Pulmonology, Endocrinology, Geriatrics and Internal Med…

COVID-19 Epidemiology Italy Mortality Public health SARS-CoV-2Infectious DiseasesSettore MED/09 - Medicina InternaPublic Health Environmental and Occupational HealthGeneral MedicineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSettore MED/13 - Endocrinologia
researchProduct

CPK increase as an occult marker of cerebrovascular disease: a case report.

2012

CPKSettore MED/09 - Medicina InternaCPK; cerebrovascular disease;cerebrovascular disease
researchProduct

A NOVEL APPROACH IN COLORECTAL CANCER AND DIABETES MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN

Abstract The link between colorectal cancer (CRC), diabetes mellitus (DM) and inflammation is well established, and polytherapy, including rapamycin, has been commonly adopted. However, due to the relatively weak response of CRC to rapamycin, combination with other molecules including metformin has become a potentially promising approach. This study is a novel approach that aimed at assessing the effect of a combination therapy of metformin and rapamycin on the control or prevention of colorectal cancer in diabetic animals, in presence or absence of probiotics. Fifty NOD/SCIDs male mice developed xenograft by inoculating HCT116 cells into the flank; they were equally divided into diabetics …

CRC DM Probiotics Inflammatory Cytokines AMPK mTOR ROS.Settore MED/09 - Medicina Interna
researchProduct

Plasma calprotectin assay in patients with acute pancreatitis

2003

CalprotectinSettore MED/09 - Medicina Internaacute pancreatitis
researchProduct

Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

2022

BackgroundTransarterial chemoembolization (TACE) is one of the most frequently applied treatments for hepatocellular carcinoma (HCC) worldwide. In this study, we aimed at evaluating whether and how TACE application and repetition, as well as the related outcome, have changed over the last three decades in Italy.MethodsData of 7,184 patients with HCC were retrieved from the Italian Liver Cancer (ITA.LI.CA) database. Patients were divided according to the period of diagnosis in six cohorts: P1 (1988–1993), P2 (1994–1998), P3 (1999–2004), P4 (2005–2009), P5 (2010–2014), and P6 (2015–2019). All the analyses were repeated in the overall patient population and in Barcelona Clinic Liver Cancer (BC…

Cancer ResearchOncologySettore MED/09 - MEDICINA INTERNAiterative treatmenthepatocellular carcinoma; iterative treatment; survival; therapeutic hierarchy; transarterial chemoembolizationtherapeutic hierarchyNeoplasms. Tumors. Oncology. Including cancer and carcinogenshepatocellular carcinomatransarterial chemoembolizationsurvivalRC254-282
researchProduct